Top Markets
Coin of the day
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
Ранг среди акций #15401
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Цена акции
$9.50
Рыночная капитализация
$357.48M
Изменение (1 день)
-0.05%
Изменение (1 год)
92.60%
Страна
US
Торговля BioAge Labs Inc. (BIOA)

Категория

История цены акций BioAge Labs Inc. (BIOA)
Наивысшая цена закрытия: $9.50 2026-09-01

Наименьшая цена закрытия: $20.04 2024-09-01
История цены акций BioAge Labs Inc. с 2024 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 19.87%
2025 48.86%
2024 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$548.98 40.40%
US
$1.03K 44.32%
NL
$121.37 -11.93%
AU
$144.39 499.38%
US
$748.60 4.92%
CH